Becker's Healthcare February 26, 2025
Alexandra Murphy

Eli Lilly plans to invest $27 billion in four new pharmaceutical manufacturing facilities in the U.S., expanding its domestic production of medications across multiple therapeutic areas.

The investment brings the company’s U.S. manufacturing commitments to more than $50 billion since 2020, according to a Feb. 26 news release from the company.

...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma, Pharma / Biotech
Follow the Money: 3D Spatial Biology, AI-Powered Imaging Biomarkers, More
AstraZeneca’s next breast cancer drug; Madrigal’s accelerating MASH launch
AI accelerates discovery of neurodevelopmental disorder-associated genes
Eikon raises $351M in one of the year’s largest biotech venture rounds
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments

Share This Article